PMV Pharmaceuticals (PMVP)
NASDAQ:PMVP
US Market
Holding PMVP?
Track your performance easily

PMV Pharmaceuticals (PMVP) Financial Statements

89 Followers

PMV Pharmaceuticals Financial Overview

PMV Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.965; its P/E ratio is -1.72; PMV Pharmaceuticals is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -20.19M$ -18.22M$ -18.90M$ -19.62M$ -20.13M
EBITDA$ -18.19M$ -17.86M$ -18.54M-$ 0.00
Net Income Common Stockholders$ -1.20M$ -15.27M$ -15.76M$ -16.64M$ -17.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 212.92M$ 197.94M$ 203.06M$ 201.92M$ 187.91M
Total Assets$ 237.54M$ 236.88M$ 252.15M$ 261.03M$ 242.22M
Total Debt$ 12.99M$ 13.02M$ 13.29M$ 12.70M$ 12.98M
Net Debt$ -199.93M$ -184.92M$ -189.77M$ -189.22M$ -174.93M
Total Liabilities$ 23.22M$ 24.20M$ 26.46M$ 23.41M$ 24.41M
Stockholders Equity$ 214.31M$ 212.68M$ 225.69M$ 237.61M$ 217.81M
Cash Flow-
Free Cash Flow$ -1.60M$ -16.78M$ -12.28M--
Operating Cash Flow$ -1.60M$ -16.18M$ -12.09M$ -15.66M-
Investing Cash Flow$ 2.32M$ 26.17M$ -2.59M$ -33.64M-
Financing Cash Flow$ 141.00K-$ 288.00K$ 33.15M-
Currency in USD

PMV Pharmaceuticals Earnings and Revenue History

PMV Pharmaceuticals Debt to Assets

PMV Pharmaceuticals Cash Flow

PMV Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis